News and Trends 4 Oct 2022
Astellas and Pantherna to work together on mRNA-based medicine through direct reprogramming
Astellas Pharma Inc. and Pantherna Therapeutics GmbH have entered into a new technology evaluation agreement for research to generate mRNA-based…